FPAS
SANA icon

Focus Partners Advisor Solutions’s Sana Biotechnology SANA Stock Holding History

Focus Partners Advisor Solutions’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.6K Sell
11,330
-2,077
-15% -$8.18K ﹤0.01% 1234
2025
Q4 		$54.6K Buy
+13,407
New +$60K ﹤0.01% 1068

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Focus Partners Advisor Solutions's SANA Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Sana Biotechnology (SANA) stake by 15% in Q1 2026, selling an estimated $8.18K and leaving 11,330 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Focus Partners Advisor Solutions first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. The position peaked at $54.6K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Focus Partners Advisor Solutions held 11,330 shares of Sana Biotechnology worth $32.6K as of Q1 2026.
  • Focus Partners Advisor Solutions sold 2,077 Sana Biotechnology shares in Q1 2026, an estimated $8.18K.
  • Sana Biotechnology made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #1234 holding.
  • Focus Partners Advisor Solutions first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Focus Partners Advisor Solutions's Sana Biotechnology position peaked at $54.6K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.